Please try another search
© Reuters. FILE PHOTO: A man who got a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine leaves a COVID-19 vaccination center in Seoul, South Korea, October 29, 2021. REUTERS/Kim Hong-Ji
By Sangmi Cha
SEOUL (Reuters) - South Korea said on Wednesday it would ramp up COVID-19 testing at schools after a sharp rise of infections among children, weeks ahead of a plan to fully reopen schools nationwide.
The surge comes as new social distancing rules aimed at a phased return to normal came into effect on Monday as a part of the country's plan to gradually move toward living with COVID-19 on the back of high vaccination rates.
South Korea has fully vaccinated nearly 90% of its adult population but only began inoculating children aged between 12 and 17 in recent weeks, administering just 0.6% of the age group with both doses so far.
"There is a growing concern as the frequency of new cluster outbreaks has been increasing, centred on educational facilities such as private tuition centres and schools," Interior and Safety Minister Jeon Hae-cheol said.
The government would expand the use of portable polymerase chain reaction (PCR) diagnostic tests for COVID-19 in schools in Seoul and neighbouring regions, and mobilise more virus-prevention personnel in overcrowded schools, he said.
South Korea plans to fully reopen schools nationwide from Nov. 22.
The country reported 2,667 new cases for Tuesday, an increase of more than 1,000 from the day earlier. Nearly one-fourth of the new cases were found in teenagers, officials said.
"The teenagers spend a lot of time in communal living such as schools and tuition centres and they are also active in social activities," Son Young-rae, a senior health ministry official, told a briefing.
"We believe that the risk of infection will inevitably rise and the confirmed cases will continue to surge stemming from these teenagers."
Other nations including Britain, Israel and Germany have also seen the spread of COVID-19 among children fuelling a rise in overall cases and have expanded vaccination programmes for children to curb infections.
The United States is set to roll out Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) COVID-19 vaccines for children aged 5 to 11 as soon as Wednesday.
South Korea has not seen a noticeable increase in seriously ill cases among teens, with just one out of 378 severe COVID-19 patients being treated in hospitals. South Korea has also reported a relatively low mortality rate of 0.78%.
Vaccination for the 12-17 age group began in October with the Pfizer/BioNTech shots.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.